This study investigates whether KMUP-l protects soluble guanylate cyclase (sGC) and inhibits vascular endothelial growth factor (VEGF) expression in lung epithelial cells in hypo xia, therapeutically targeting epithelial proinflammation. H441 cells were used as a representative epithelial cell line to examine the role of sGC and VEGF in hypo xia and the anti-proinflammatory activity of KMUP-l in normoxia. Human H441 cells were grown in hypoxia for 24-72 h. KMUP-l (1, 10, 100 J.1M) arrested cells at the GO/Gl phase of th e cell cycle, reduced cell surv ival and migration, increased p211p27, restored eNOS, increased soluble guanylate cyclase (sGC) and PKG and inhibited Rho kinase II (ROCK-II). KM UP-l (0.001-0.1 J.1M) concentration dependently increased eNOS in normoxia and did not inhibit phosphodiesterase-SA (POE-SA) in hypo xic cells. Hypo xia-induced factor-In (HIF-la) and VEGF were suppressed by KMUP-l but not by L-NAME (100 J.1M). The PKG inhibitor Rp-8-CPT-cGMPS (10 J.1M) blunted the inhibition of ROCK-II by KMUP-l. KMUP-l inhibited thromboxane A2-mimetic agonist U46619-induced POE-SA, TNF-a (100 ng/ml)-induced iNOS, and ROCK-II and associated phospho-p38 MAPK, suggesti ng multiple anti-proinflammatory activ ities. In addition, increased p211p27 by KMUP-l at higher concentrations might contribute to an increased Bax/BcI-2 and active caspase-3/procaspase-3 ratio, concomitantly causing apoptosis. KMUP-l inhibited ROCK-IINEGF in hypoxia, indicating its anti-neoplastic and anti-inflammatory properties. KMUP-l inhibited TNF-a-induced iNOS and U46619-induced POE-S A and phospho-p38 MAPK in normoxia, confirming its anti-proinflammatory action. KMUP-l could be used as an anti-proinflammatory agent to reduce epithelial inflammation.
in pulmonary hypertension and proliferation (4) (5) (6) . In this study, H441 cells are used to examine the role of VEGF in hypoxia and the anti-pro inflammation activity of KMUP-l in normoxia. We investigated the involvement of cGMP/PKG for inactivating ROCK and down-regulating VEGF in H441 cell growth.
KMUP-l (7-[2-[ 4-(2-chlorobenzene)piperazin yl]ethyl]-I ,3-dimethylxanthine), a xanthine-based derivative, was demonstrated to increase cyclic nucleotides and stimulate K+ channels resulting in relaxation in aortic, corporeal cavernosa and tracheal smooth muscles (7) (8) (9) , and to activate BK ca channels in rat basilar artery myocytes (10) . It relaxed tracheal smooth muscles by activating soluble guanylate cyclase (sGC) and epithelial nitric oxide synthase (NOS), leading to increasing cytosolic cGMP (9) . Moreover, KMUP-l inhibited TNFa-induced iNOS, involving sGC activation-associated increases of cGMP/PKG in tracheal smooth muscle cells (11). Accordingly, KMUP-I is suggested to be able to activate epithelial NOS and sGC, protect sGC from hypoxic stress-induced damage and inhibit proliferation, proinflammation and cell migration ( 12) . cGMP enhancing activity found by the nonsteroidal anti-inflammatory sulindac was reported to inhibit carcinogenesis and to modulate cGMPdependent protein kinase signaling pathways in colon cancer cells (13) . Moreover, suppression of cGMP-specific PDE5 was reported to promote apoptosis and inhibit the growth of HT29 cells (14) , similar to the anti-proliferative effect of sildenafil in pulmonary artery cells (15) . YC-l, a sGC activator with NO-independent cGMP-enhancing activity, displayed anti-proliferative effects in HA22T cells (16) , anti-angiogenesis effects in umbilical vascular endothelial cells (17) , anti-cancer activity in human prostate cancer PC-3 cells (18) and antipro inflammatory COX-2 expression in pulmonary epithelial cells (19) . Whether KMUP-l affects the growth of H441 cells, mediated by cGMP/PKGenhancing activity, remains to be resolved.
ROCK may play an important role in regulating biological events in cells, including proliferation, differentiation, and survival/death. Blockade of ROCK promotes axonal regeneration and neuron survival and inhibition ofROCK by fasudil represents a therapeutic perspective by irihibiting inflammatory responses (20) . KMUP-l inactivates ROCK by cGMP/PKG, indicating similar anti-proinflammatory activity to fasudil (4, 20) . Downstream of the cGMP/ PKG pathway, ROCK is involved in cancer cell invasion and migration (21) . However, the effect of cGMP-enhancing KMUP-l on ROCK expression in H44l cells remains unclear.
VEGF is not only an important pro-angiogenic factor necessary for tumor growth, but also a target of inflammation (3) . It is induced by a number of stimuli, including hypoxia, evidenced by hypoxiainduced factor-l a (HIF -1a) expression, a hypoxiaactivated transcription factor that can regulate the VEGF gene (22) . Hypoxic regulation of VEGF has also been described through the induction of PI3K1Rho/ROCK and c-Myc, which is a target of the PI3K1ROCK pathway, and which can regulate the VEGF promoter through a binding element (23) . Unexpectedly, YC-l is the representative NO-independent cGMP enhancer, displaying inhibitory effects on VEGF and HIF-la in Hep3B cells (24) . YC-l also showed anti-proliferative and anti-angiogenic effects in vascular endothelial cells (25) and various cancer cells (26) , surprisingly via a cGMP-independent pathway (25) . We investigate whether a cGMP enhancer KMUP-l, like YC-l, inhibits proliferation via VEGF pathway in H441 cells.
Cyclin-dependent kinase (CDK) inhibitory proteins p21 and p27 are associated with antiproliferation activity and upregulated by endogenous or exogenous NO (27) . Upregulation ofp21 and p27 proteins, 2 downstream markers ofmitogen-activated protein kinases (MAPK) in cell proliferation, have been shown by YC-l in a cGMP-independent manner, in contrast to cGMP-dependent sulindac (13) . PKG activation is found to phosphorylate p21activted kinase (Pak), which has a central role in regulating cell motility, morphology and cell cycle progression (28) . By contrast, p38 MAPK plays an important role in inflammatory cells, proliferation of airway structural cells and cell survival (29) .
This study aims to explore the effects of KMUP-1 on cell survival and expression of NOS/sGC/PKG, ROCK/VEGF/HIF-la/p38 MAPK and PDE-5A1 iNOS in H441 lung epithelial cells, and its implication for anti-proinflammatory or anti-neoplastic therapy.
MATERIALS AND METHODS

Reagents
KMUP-I HCI was synthesized in our laboratory and dissolved in distilled water. L-NAME, propidium iodide (PI), OMSO, bovine serum albumin (BSA), glycerol, and Tween-20 were purchased from Sigma-Aldrich (St. Louis , MO) . Fetal bovine serum (FBS), glutamine, and penicillin/streptomycin were obtained from Gibco BRL (Grand Island, NY) . Donkey anti-goat IgG horseradish peroxidase-conjugated secondary antibodies and antibodies against ROCK-II (a representative of Rho kinase), p38 MAPK, eNOS , sGC, PKG, p21, p27, Bax, Bcl-2, VEGF, HIF-I a and p-actin were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-eNOS, anti-HIF-la, and goat anti-mouse IgG-HRPO were obtained from BO transduction Laboratories" (BO Biosciences, San Jose, CA).
Cell culture and hypoxia
Human lung adenocarcinoma NCI-H441 cell lines were obtained from theAmerican Type Culture Collection and were cultured in RPMI 1640 medium supplemented with 2 mM glutamine, penicillin/streptomycin and 10% FBS. Cells were grown in a humidified atmosphere containing 5% CO 2 at 37°C. Cells were grown under normoxia (20% O 2 ) and hypoxia (1% O 2 ) , To achieve hypoxia, a pre-analyzed gas mixture (95% N 2-5% CO 2 ) was infused into an air chamber.
To test cell survival and proliferation, H441 cells were cultured in 24-well plates (l O'cells/well) and incubated with different concentrations of KMUP-I for various lengths of time followed by MTT assay as described previously (5) . Cells were treated with various concentrations of KMUP-I (0.0 I-I 00 11M) for 48 h to examine the protein expression of eNOS, sGC, POE-5A, PKG, p38 and cell cycle regulators p21 and p27 or treated with I 11M KMUP-I for 3-72 h in hypoxia to examine the protein expression ofHIF-la and VEGF.
Cell cycle distribution
Cells were harvested ' by trypsinization, washed with PBS, and re-suspended in 75% ethanol in PBS and kept at 4°C for at least 30 min. Before analysis, cells were washed again with PBS, resuspended and incubated for 30 min in propidium iodide staining solution containing 0.05 mg/ml propidium iodide, I mM EOTA, 0.1% Triton X-IOO and I mg/ml RNase A in PBS. The suspension was then passed through a nylon mesh filter and analyzed on a flow cytometry . (Coulter Epics XL-MCL, Beckman Coulter, USA).
Protein expression by Western blotting
To determine the expression levels of eNOS, iNOS, sGC, PKG , HIF-Ia, VEGF, ROCK-II , p38 MAPK , Bax, Bcl-2 and cyclin-dependent kinase (COK)-inhibitory proteins p21 and p27 in the H441 cell line, the total proteins were extracted and Western blot analyses were performed as described previously. Briefly, H441 cells were cultured in IO-cm dishes . After reaching subconfluence, the cells were rendered quiescent and then treated with various times or concentrations of KMUP-I. In some experiments, cells were pretreated with specific inhibitors as indicated, then followed by KMUP-l. To examine the anti-proinflammation activities, measurement of iNOS was performed in the presence of TNF-a (100 ng/ml) .
In addition, expression of POE-5A was measured in the presence of TXA2-mimetics U46619 (5 11M) for 30 min after pre-incubation of cells with KMUP-l. To confirm the inhibition of ROCK-II by KMUP-l, Y27632 (10 11M) was added as a reference compound. After incubation, the cells were washed with PBS (pH 7.4), incubated with extraction buffer (Tris 10 mM, pH 7.0, NaCI 140 mM, PMSF 2 mM, OTT 5 mM, NP-40 0.5%, pepstatin A 0.05 mM and leupeptin 0.2 mM) with gentle shaking, and then centrifuged at 12,500 g for 30 min. The cell extract was then boiled in a ratio of I :I with sample buffer (Tris 100 mM, pH 6.8, glycerol 20%, SOS 4% and bromophenol blue 0.2%). Electrophoresis was performed using 10% SOS-polyacrylamide gel (2 h, 100 V, 40 rnA, 50 mg protein per lane). Separated proteins were transferred to PVOF membranes (90 min, 100 V), treated with 5% fat-free milk powder to block the nonspecific IgGs, and incubated for I h with specific antibody. The blot was then incubated with anti-mouse or anti-goat IgG linked to alkaline phosphatase (1:I000) for I h. Protein bands were visualized by enhanced chemiluminescence reagents (GE Healthcare Bio-Sciences Corp., Piscataway, NJ).
Cell migration assay
Migration of H441 cells was assayed using a wound assay model (5) , in which cells were grown to 90% confluence on 6-well plates. Wounds were produced by scraping the cell monolayer with a fine razor across the diameter of the well and washed four times with medium to remove cell debris. The wound edge was viewed and photographed under a microscope (Eclipse TS 100, Nikon , Tokyo, Japan) before and after culture for 24 and 48 h in serum-free OMEM in the presence of KMUP-1 and Y27632 at 10 11M. The distance the cells migrated from the wound surface was then manually measured. Wound width measurements were collected from two different (maximal and minimal) locations in the same well and averaged as one measurement.
Statistical analysis
All data are expressed as the mean ± S.E., n=4 .
Statistical differences were determined by independent and paired Student's t-test in unpaired and paired samples, respectively. Whenever a control group was compared with more than one treated group, the one-way or twoway ANOVA was used. When the ANOVA manifested a statistical difference, results were further analyzed with Dunnett's or Tukey test. A probability value (pvalue) less than 0.05 was considered to be significant. Analysis of data and plotting of figures were carried out with SigmaStat: Version 2.03 and SigmaPlot: Version 8.0 (Systat Software, Point Richmond, CA) and run on an IBM-compatible computer.
RESULTS
Cell survival rate and cell cycle
In normoxia and hypoxia conditions, incubation of H441 cells with KMUP-I (l, 10, 100 flM) for 24, 48 and 72 h inhibited the survival rate of cultured cells, showed significant inhibition at > Ia flM ( 
Normoxic protein expression of eNOSlsGCaJPKGI PDE-5A
Cells were incubated with or without KMUP-I for 48 h in normoxia. KMUP-I (10 flM) stimulated the expression of eNOS maximally at 72 h in H441 cells ( Fig 
Hypoxic protein expression of eNOSlsGCIPDE-5AI HIF-laJVEGF
eNOS in H441 cells was sharply down-regulated at 12 h and was significantly restored by KMUP-I (l0 uM) at 48 and 72 h ( Fig. 2A ). Sole NOS inhibitor L-NAME (lOa flM) can not significantly reduce eNOS (Fig. 2C ). However, increased eNOS expression by KMUP-l at 0.1 and I flM was reduced by L-NAME, respectively ( Fig. 20) . To examine the hypoxia-resistant activity of sGCa and treatment with KMUP-I, cells were incubated with or without KMUP-I for 48 h. As shown in Fig. 3A , sGCa in H441 cells was significantly increased by KMUP-I at 100 flM. sGC was not down-regulated by hypoxia during 48 h at both concentrations. PKG in H441 cells were significantly increased by KMUP-I (10, 100 flM) from control to 130.1±11.7% andI66.6±18.0%, respectively ( Fig. 3B ). Inflammatory TXA2 mimetic agonist U46619 (5 flM) could not induce increase of POE-5A ( Fig. 3C ).
Expression of HIF-I a appeared following exposure to hypoxia for 3 h and achieved the maximum at 6 hand 12 h. After exposure to hypoxia for 18-24 h, HIF-I a protein was fast decreased. VEGF expressions were increased and the inhibitory effects of KMUP-I (l flM) at 12, 18, 24, 48 and 72 h were 59.9±3.0%, 39.6±4.4%, 37.0±5.1 %, 50.7±3.5% and 44.2±3.3%, respectively ( Fig. 4B ). KMUP-I (l flM) inhibited HIF-Ia expression at 12 hand achieved the maximum at 24 h ( Fig. 4C ). However, the action was not observed by pretreatment with L-NAME. Combination of KMUP-I with L-NAME did not show any further inhibition on HIF-Ia protein in hypoxic state ( Fig. 4C ). HIF-Ia expression was concentration-dependently inhibited by KMUP-I (1.0-100 flM) (Fig. 40) . 
cGMP-independent p21 andp27
In hypoxia, KMUP-I (10, 100 flM) increased p2l to 151.7±7.7% and 135.1±14.7%, respectively ( to I72.4±19.5% and 242 .2±21.5%, respectively (Fig ,  5C ). However, Rp-8-CPT-cGMPS (10 )lM) could not inhibit KMUP-I-induced expression of p21 and p27 expression ( Fig . 5D ) . Serum starvation of cells also showed the increased expression of p2 1 and p27 (data not shown).
In normoxia, p2 1 expression was increased by KMUP-I (10, 100 )lM) to 18 1.2±17.6%, 172.9±18.1% compared to control. p27 expression was increased to 162.5±12.5% and 20 1.6±23.5%, respectively (Fig.  5C ). Rp-8-C PT-cGMPS (10 )lM) could not inhibit KMUP-I-induced p21 and p27 expression ( Fig.  5B, 5D ). Serum starvation of cells also increased expression of p21 and p27 (data not shown) .
Apoptotic Bax/Bcl-2 and caspase 3
KMU P-I (10, 100 )lM) increased Bax from control to 125.6± 11.4% and 103.6± 10.8%, respectively, reduced Bcl-2 from control to 31.9±1.2% in normoxia and 56.5±1.3% in hypoxia, and increased the Bax/Bc1-2 ratio concentration-dependently ( Fig .  6A, 6B ). The Bax/Bc1-2 ratio increased more in hypoxia than in normoxia. Bax in serum starvation (SF) increased more in normoxia than in hypo xia. Pretreatment with L-NAME or Rp-8-CPT-cGMP inhibited KMUP-I (100 )lM)-induced expression of Bax and Bc1-2 in hypoxia ( Fig. 6B, 6C ). The expression ratios of active-caspase-3/pro-caspase-3 with KMU P-I (1, 10, 100 )lM) are shown in Fig. 6D indicating being increa sed more in normoxia than in hypoxia.
Anti-proinfiammation, phosphorylation of p38 MAPK and TNF-a-induced iNOS
The relative optical density ratio indicated the expression ratio of phospho-p38 MAPK/total p38 MAPK. In the serum-free group this expression ratio was decreased in normo xia (n=4, p<0.05) , but insignificantly in hypoxia. KMUP-l ( 10 and I00 M) decreased the expres sion ratios to 58.9±7.1% and 50.9±9.1% in normo xia as well as 70.6±6.6% and 67.1±9.4% in hypoxia (n=4, p<0.05) ( Fig. 7A ). TNF-a (100 ng/ml) increa sed the expres sion of iNOS as previousl y found in tracheal smooth muscle cells (9) . KMUP-l (I, 10, 50, 100~M) did inhibit TNF-a-induced iNOS and blunt these results to normal levels at 50 and 100~M under normox ic and hypoxic conditions (Fig. 7B) .
Cell migration and ROCK-II inhibition
KMUP-l inhibited the migration acti vity of H441 lung epith elial cells in normo xic and hypoxic conditions. As shown in photography, KMUP-l o~~~!~~~; (>50 11M) significantly reduced the migration of cells across the wound width of culture after culturing for 48 hours . The effect is more prominent in normoxia than in hypoxia. ROCK-II inhibitor Y27632 (l0 11M) also showed the inhibition activity in normoxia, but not in hypoxia ( Fig. 8 ).
DISCUSSION
KMUP-l contributes to airway smooth muscle relaxation, and may relieve COPD due to epithelial cell inflammation (7) . KMUP -l's inhibition of VEGF is indicative of its anti-angiogenesis, antiproinflammatory and apoptotic acti vity. Due to the cross-utilization ofmo lecu les and pathways invo lved in opposing processes like cell pro liferation, survi val and death, our findings suggest that VEGF inh ibition would be related to p21/p27-dependent ce ll growth arrest. Taken together, KMUP -l might have anti-proliferation, anti-proinflammation and antimigration effects in H441 cells .
Angiogenesis is stimulated by VEGF, which can be induced by NO , i.e. NO is an important pro-angiogenic factor to promote the cell growth. Hypo xia is a potent inducer of VEGF expression, while HIF-l a plays a key transcription role in hypoxia-mediated VEGF gene upregulation (30) . NO as well as hypo xia is reported to up-regulate the VEGF gen e by enhancing HIF-Ia acti vity, and this action seem s to be associ ated with unwanted angi ogenesis in cancer treatment (3 I). Although KMUP-I ( I~LM ) increased eNOS ex pression in normoxia, but it showed no significant VEGF expression, indicating no pro-angiogenic action per se. Notably, KMUP-I (0.1-1 00~lM) inhibited the expression of VEGF and HIF-I a in hypox ia and these proteins can be good targets for proliferation and angiogenesis. We suggest that KMUP-l not only surmounts the possible NO -mediated VEGF production in hypoxia , but also has potent anti- proliferation and anti-angiogenesis effects. KMUP-l decreased ROCK-II expression and associated cell migration activity, thus inhibiting the ROCK-II and/or VEGF pathway, which resulted in anti-pro liferation or anti -angiogenesis (23) . Increased ROCK indicates contra-regu lation by reduced eNOS in hypoxia (4) . The decrease in ROCK-II by KMUP -l was blunted by the antagonist Rp-8-CPT-cGMP, indicating the cGMP-dependent pathway was involved. Activation of PKG is able to induce growth inhibi tion and apoptosis and also to inhibit cell migration in human cancer cells (32) . KMUP-I enhanced sGC and PKG expression under both normoxia and hypoxia in H441 cells, suggesting it is able to stimulate apoptosis and to inhibit cell growth and migration. Activation of sGC, contributing to cGMP-mediated upregulation ofPKG, might protect cells from death in hypoxia. From our findings, we speculated that inhibition of cell growth by KMUP-I at lower concentrations is related to cGMP/PKG, but apoptosis by KMUP-l at higher concentrations is related to increased ONOO-and an up-regulated p21/p27 and Bax/Bcl -2 ratio. Although eNOS inhibited and POE-SA up-regulated in hypoxia, opposing the accumulation of cGM P, KMUP -I can directly activate sGC to increase cGMP and PKG (10-11). PKG activity is increased by KMUP-I in both normoxia and hypoxia, therefore, we suggest that KMUP-l protects from hypoxia-induced cell death via sGC/PKG. In the cell cycle, CDK-inhibitory proteins p21 and p27 are markers of DNA replication during cell progression and are usually activated by p53 after DNA damage. Upon genotoxic damage, p21 and p27 contribute to cell cycle arrest at the GO/G1 check points through diverse mechanisms. However, growing evidence supports the role of p21 and p27 in regulation at translation levels (27) . KMUP-l (10, 100 uM) inhibited the proliferation of H441 cells in hypoxia, but showed no inhibition below 1 /-lM. KMUP-l increased the expression of p21 and p27 upon stress stimulation by hypoxia, indicating an effect on translation levels during cell growth. Moreover, KMUP-l-induced p21 and p27 expression were unaffected by Rp-8-CPT-cGMP, suggesting cGMP-independent cell cycle progression as seen with YC-l (16) (17) .
KMUP-l increased Bax and decreased Bcl-2 expression in hypoxia, resulting in an increased Bax/ Bcl-2 ratio. Accordingly, KMUP-l enhanced the expression of caspase-3, indicating apoptotic ability in H441 cells. KMUP-l 's inhibition ofVEGF would be suggested to reduce the survival rate, cell growth and angiogenesis. KMUP-l did have significant anti-proliferative responses and cell cycle arrest at the GO/G 1 phase . However, it did not foster more cell death (> 100 11M, data not shown) in normoxic and hypoxic conditions. Taken together, we suggest that KMUP-l's low cytotoxicity in hypoxic H44l cells cou ld possibly be due to limited downregulation of VEGF and/or ROCK and phospho-p38 MAPK inhibition activity, i.e. anti-inflammatory signaling other than apoptosis. Multiple action pathways, including competition between apoptosis and survival, are suggested to be regu lated by KMUP -l at different concentrations in hypoxic H44l cells. TXA2 plays an important role in airway inflammation, obstruction and hyperresponsiveness. To elucidate the inhibitory activity of KMUP-I on POE-5A, the TXA2-mimetic U466l9 was used to increase POE-5A in epithelial cells before KMUP-I treatment (4). To expose the involvement of iNOS, TNF -a was used to induce iNOS and incubated with KMUP-I. KMUP-I atten uates TNF -a-induced iNOS and abolishes at >50 11M in normoxia and hypoxia. KMUP-I inhibits U466l9-induced POE-5A and TNF -a-induced iNOS, synergistically protecting from cGMP hydrolysis and increased inflammatory airway obstruction. Although it remains unclear how the TXA2-mimetic U466 I9 induces the expression ofPOE-5A, the underlying mechanism of action will be examined in the near future .
p38 MAPK, a pro-inflammatory signaling protein, is believed to be primari ly responsible for regulation of inflammation. A variety of factors, including hypoxic stress, activate p38 MAPK expression. Once activated, p38 MAPK phosphorylates the downstream substrates to initiate a signal cascade that regulates a variety of pro-inflammatory mediators (29) . KMUP -I 's ability to reduce phospho -p38 MAP K expression indicates its potential for inhibiting this pro-inflammatory pathway. KMUP-I has been shown to inhibit TNFa-induced iNOS and TXA2 -mimetic U46619 -induced POE-5A, further confirming its anti -proinflammatory mer its. ROCK inhibitor has been described to possess vasodilatory and anti-inflammatory activities in isolated tissues and cultured cells (20) . Note that the upstre am activators of p38 and Rho/ROCK signa ling are responsible for effects on the basal phosphorylation of alternate sites on Smad2/3 . Obviously, the p38 MAPK and Rho/ROCK pathways are necessary for TGF-p-mediated cell growth inhibition (33) . Otherwise, p38 MAPK functions downstream of the RholROCK pathway regu late synthesis and secretion of MCP-I (34) . Therefore, KMUP-] might also inhibit proinflammation by ROCK inhibition in epithelial ce lls. Although KMUP-I ( 10 JlM) showed significantly suppressive effects on ROCK-H, the anti -migration effect was achieved with >50 JlM. This discrepanc y cou ld be explained by the fact that protein expression seems more sensitive than cell migration and it remains to be furthe r investigated. In summary, KMUP-l atte nuates ROCK-II , p38 MAPK, VEGF, and TNF-a-induced iNOS expression an d increases eNOS, sGC and PKG expression during the proliferatio n of hypoxic H44 l ce lls, providing anti -pro inflammation benefits as illustrated in Fig . 9 . The most active concentration to stim ulate eNOS, compared to other signaling, is >0 .00 I JlM.
Although KMUP-l has a wide range of biologic responses at different concentrations, its cGMPdependent action shows to be beneficial to airway inflammation at lower concentrations. The apoptotic response of KM UP-l at higher con centrations indicates that it wo uld not be a good candidate for the development as a chemotherapeutic agent. In conclusion, KMU P-l is suggested to be useful for the treatment oflung epithelial inflammation such as that found in COPD.
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